University of Sydney
Gerald Münch mostly deals with Glycation, Oxidative stress, Biochemistry, Alzheimer's disease and Neuroprotection. The various areas that he examines in his Glycation study include Inflammation, Cell damage and Peptide. His work deals with themes such as Cancer research, Neurodegeneration, Disease, Pathology and Nitrotyrosine, which intersect with Oxidative stress.
His Neurodegeneration study combines topics in areas such as Neurotoxicity, Programmed cell death, Neuroscience and Intracellular. While the research belongs to areas of Alzheimer's disease, Gerald Münch spends his time largely on the problem of Immunology, intersecting his research to questions surrounding Senile plaques. Gerald Münch has included themes like Lipid peroxidation, Surgery and Ageing in his Neuroprotection study.
Gerald Münch spends much of his time researching Biochemistry, Glycation, Oxidative stress, Internal medicine and Endocrinology. His research on Biochemistry often connects related areas such as Molecular biology. Gerald Münch interconnects Alzheimer's disease, Nitric oxide and Intracellular in the investigation of issues within Glycation.
His Oxidative stress research incorporates elements of Antioxidant, Inflammation, Neurodegeneration, Neuroprotection and Pathology. In his research on the topic of Inflammation, Neuroinflammation is strongly related with Pharmacology. His study in Neurodegeneration is interdisciplinary in nature, drawing from both Neuroscience and Programmed cell death.
Neuroinflammation, Anti-inflammatory, Pharmacology, Microglia and Inflammation are his primary areas of study. His Neuroinflammation study integrates concerns from other disciplines, such as Alzheimer's disease and Neuroscience. His studies deal with areas such as No production, Nitric oxide, Downregulation and upregulation, Biochemistry and Traditional medicine as well as Anti-inflammatory.
His Biochemistry research is multidisciplinary, incorporating elements of Choline acetyltransferase and Molecular biology. His research integrates issues of Macrophage, Senile plaques and Pathology in his study of Inflammation. His work on RAGE is typically connected to In situ hybridization as part of general Glycation study, connecting several disciplines of science.
His scientific interests lie mostly in Pharmacology, Neuroinflammation, Microglia, Curcumin and Neuroprotection. His Neuroinflammation study combines topics from a wide range of disciplines, such as Alzheimer's disease and Neurodegeneration. His work on Amyloid precursor protein as part of his general Alzheimer's disease study is frequently connected to Epigallocatechin gallate, thereby bridging the divide between different branches of science.
The various areas that Gerald Münch examines in his Neurodegeneration study include Diabetes mellitus, Glycation and Cell cycle, Cyclin D1. His biological study deals with issues like Cytokine, which deal with fields such as Inflammation. His Neuroprotection study combines topics in areas such as Apigenin and Resveratrol.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
Velandai Srikanth;Annette Maczurek;Thanh Phan;Megan Steele.
Neurobiology of Aging (2011)
Advanced glycation endproducts in ageing and Alzheimer's disease.
Gerald Münch;Johannes Thome;Paul Foley;Reinhard Schinzel.
Brain Research Reviews (1997)
Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.
G. Münch;R. Schinzel;C. Loske;A. Wong.
Journal of Neural Transmission (1998)
Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds.
Lin Zhang;Anjaneya S Ravipati;Sundar Rao Koyyalamudi;Sang Chul Jeong.
Journal of Agricultural and Food Chemistry (2011)
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias
Lina Holmquist;Grant Stuchbury;Katrin Berbaum;Sonja Muscat.
Pharmacology & Therapeutics (2007)
Brain atrophy in type 2 diabetes: regional distribution and influence on cognition.
Chris Moran;Chris Moran;Thanh G. Phan;Thanh G. Phan;Jian Chen;Leigh Blizzard.
Diabetes Care (2013)
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
Annette Maczurek;Klaus Hager;Marlene Kenklies;Matthew Sharman.
Advanced Drug Delivery Reviews (2008)
Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA
Gerald Münch;Regina Keis;Andrea Weßels;Peter Riederer.
Clinical Chemistry and Laboratory Medicine (1997)
Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation.
Hans-Joachim Lüth;Gerald Münch;Thomas Arendt.
Brain Research (2002)
Alpha-lipoic acid as a new treatment option for Azheimer type dementia
Klaus Hager;Andres Marahrens;Marlene Kenklies;Peter Riederer.
Archives of Gerontology and Geriatrics (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: